The molecular mechanisms though which inhaled inorganic particles cause interstitial pulmonary fibrosis (IPF) are being investigated. Since there are numerous potential mediators that will be expressed during disease development, it is essential that studies focus on selected molecules that could be key. We have shown that tumor necrosis factor alpha receptor knock out (TNF-alphaRKO) mice are protected from the fibrogenic effects of inhaled asbestos fibers. These animals exhibit reduced expression of other cytokines such as platelet-derived growth factor, transforming growth factor alpha (TGF-alpha) and TGF-beta1, even though TNF-alpha expression remains up-regulated. Thus, we have focused this proposal on the hypothesis that TNF-alpha mediates the development of interstitial pulmonary fibrosis through regulation of TGF- beta production.
Four Specific Aims will directly test this postulate: 1) To demonstrate reduced TGF-beta expression in the lungs of asbestos- exposed TNF-alpha receptor knockout (TNF-alphaRKO) mice by in situ hybridization (ISH) and immunohistochemistry (IHC). Our preliminary data show that these mice lack expression of TGF-beta1 after asbestos exposure. If this proves to be true in the final analysis, an important step in testing the postulate will be accomplished. 2) a. To establish whether or not latent or active TGF-beta transduced by adenovirus vector into the lungs of the TNF-alphaRKO mice induces fibroproliferative lung disease in the fibrogenic-resistant mice. b. To expose the virally-transduced animals to asbestos and establish TGF-beta expression as a mediator of fibrogenesis. If TGF-beta1 transduced by an adenovirus vector restores susceptibility to developing fibrogenesis, further evidence of a central role of this growth factor will be in hand. 3) To maintain, in culture, alveolar epithelial and mesenchymal cells from TNF-alphaRKO and TGF-betaKO mice to determine if TNF-alpha receptor signaling is necessary to up-regulate TGF-beta and collagen gene expression in vitro after asbestos exposure. The influence of TNF-alpha on expression of TGF-beta1 and pro alpha1(I) collagen (as postulated) is completely unknown in primary pulmonary cells fro normal and knockout through treatment of mesenchymal cells with antisense vectors directed at expression of the TNF-alpha and TGF-beta genes, As a potential therapeutic approach, we show that an anti-sense TGF-beta1 gene vector blocks expression of TGF-beta1 as well as pro alpha1(I) collagen after treatment with TNF-alpha.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
2R01ES006766-06
Application #
6011700
Study Section
Lung Biology and Pathology Study Section (LBPA)
Project Start
1994-04-11
Project End
2004-08-31
Budget Start
1999-09-15
Budget End
2000-08-31
Support Year
6
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Tulane University
Department
Pathology
Type
Schools of Medicine
DUNS #
City
New Orleans
State
LA
Country
United States
Zip Code
70118
Lin, Rui; Degan, Simone; Theriot, Barbara S et al. (2012) Chronic treatment in vivo with ýý-adrenoceptor agonists induces dysfunction of airway ýý(2) -adrenoceptors and exacerbates lung inflammation in mice. Br J Pharmacol 165:2365-77
Miller, Jeffrey D; Lankford, Susan M; Adler, Kenneth B et al. (2010) Mesenchymal stem cells require MARCKS protein for directed chemotaxis in vitro. Am J Respir Cell Mol Biol 43:253-8
Sullivan, Deborah E; Ferris, Marybeth; Nguyen, Hong et al. (2009) TNF-alpha induces TGF-beta(1) expression in lung fibroblasts at the transcriptional level via AP-1 activation. J Cell Mol Med :
Salazar, Keith D; Lankford, Susan M; Brody, Arnold R (2009) Mesenchymal stem cells produce Wnt isoforms and TGF-beta1 that mediate proliferation and procollagen expression by lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 297:L1002-11
Sullivan, Deborah E; Ferris, Marybeth; Pociask, Derek et al. (2008) The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo. J Immunotoxicol 5:145-9
Spees, Jeffrey L; Pociask, Derek A; Sullivan, Deborah E et al. (2007) Engraftment of bone marrow progenitor cells in a rat model of asbestos-induced pulmonary fibrosis. Am J Respir Crit Care Med 176:385-94
Sullivan, Deborah E; Ferris, MaryBeth; Pociask, Derek et al. (2005) Tumor necrosis factor-alpha induces transforming growth factor-beta1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. Am J Respir Cell Mol Biol 32:342-9
Li, Jian; Poovey, Halet G; Rodriguez, Juan Felipe et al. (2004) Effect of platelet-derived growth factor on the development and persistence of asbestos-induced fibroproliferative lung disease. J Environ Pathol Toxicol Oncol 23:253-66
Manuel, Raymond C; Hitomi, Kenichi; Arvai, Andrew S et al. (2004) Reaction intermediates in the catalytic mechanism of Escherichia coli MutY DNA glycosylase. J Biol Chem 279:46930-9
Sanchez, Ana M; Minko, Irina G; Kurtz, Andrew J et al. (2003) Comparative evaluation of the bioreactivity and mutagenic spectra of acrolein-derived alpha-HOPdG and gamma-HOPdG regioisomeric deoxyguanosine adducts. Chem Res Toxicol 16:1019-28

Showing the most recent 10 out of 28 publications